Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-8.4%
5Y CAGR+0.6%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-8.4%/yr
Annual compound
5Y CAGR
+0.6%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 37.55% |
| 2024 | 22.44% |
| 2023 | 25.62% |
| 2022 | 48.91% |
| 2021 | 65.67% |
| 2020 | 36.53% |
| 2019 | 29.06% |
| 2018 | -52.04% |
| 2017 | 115.84% |
| 2016 | 8.61% |